• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛至碱N-氧化物在晚期癌症患者中的I期研究。

Phase I study of indicine N-oxide in patients with advanced cancer.

作者信息

Ohnuma T, Sridhar K S, Ratner L H, Holland J F

出版信息

Cancer Treat Rep. 1982 Jul;66(7):1509-15.

PMID:7093966
Abstract

Indicine N-oxide is a pyrrolizidine alkaloid isolated from Heliotropium indicum, one of the widely used herbs in Ayurvedic medicine. Thirty-seven patients with solid tumors received the drug: 15 men and 22 women (mean age, 53 years). All had had prior chemotherapy, and 25 had had prior radiotherapy. Eighty-four percent had a performance status of 0-3 (Cancer and Leukemia Group B criteria). The drug was given as a short infusion over 15 minutes and repeated with a median interval of 4 weeks. Doses were escalated from 1 to 9 g/m2. A total of 55 courses were evaluable. Dose-limiting toxic effects were leukopenia and thrombocytopenia, and the toxicity was cumulative with repeated doses. Other toxic effects included nausea and vomiting, anemia, and hepatic dysfunction. The hematologic toxicity tended to be more pronounced in patients with hepatic dysfunction, poor marrow reserve, and heavy prior chemotherapy and radiotherapy. There were no complete or partial responses. One patient with skin melanoma and another with ovarian carcinoma had improvement lasting 2 months. The maximally tolerated dose is 9 g/m2 in our population. A recommended dose for therapeutic study is 7 g/m2. High-risk patients should be started at a dose of 5 g/m2. The treatment may be repeated at 4-week intervals with close monitoring of wbc and platelet counts. Dose reductions may be necessary for repeated courses.

摘要

印度天芥菜碱氮氧化物是一种从印度天芥菜中分离出的吡咯里西啶生物碱,印度天芥菜是阿育吠陀医学中广泛使用的草药之一。37例实体瘤患者接受了该药物治疗:15名男性和22名女性(平均年龄53岁)。所有患者均接受过先前的化疗,25名患者接受过先前的放疗。84%的患者体力状况为0 - 3(癌症和白血病B组标准)。药物通过15分钟的短时间输注给药,中位间隔4周重复给药。剂量从1 g/m²逐步增加至9 g/m²。总共55个疗程可评估。剂量限制性毒性反应为白细胞减少和血小板减少,且毒性随着重复给药而累积。其他毒性反应包括恶心、呕吐、贫血和肝功能障碍。血液学毒性在肝功能障碍、骨髓储备差以及先前接受过大量化疗和放疗的患者中往往更为明显。没有完全缓解或部分缓解的病例。1例皮肤黑色素瘤患者和另1例卵巢癌患者病情改善持续了2个月。在我们的研究人群中,最大耐受剂量为9 g/m²。治疗性研究的推荐剂量为7 g/m²。高危患者应以5 g/m²的剂量开始治疗。治疗可每4周重复进行,密切监测白细胞和血小板计数。重复疗程可能需要减少剂量。

相似文献

1
Phase I study of indicine N-oxide in patients with advanced cancer.牛至碱N-氧化物在晚期癌症患者中的I期研究。
Cancer Treat Rep. 1982 Jul;66(7):1509-15.
2
Phase I trial of high-dose melphalan, high-dose etoposide and autologous bone marrow re-infusion in solid tumors: an Eastern Cooperative Oncology Group (ECOG) study.高剂量美法仑、高剂量依托泊苷及自体骨髓回输用于实体瘤的I期试验:一项东部肿瘤协作组(ECOG)研究
Bone Marrow Transplant. 1994 Sep;14(3):443-8.
3
Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.在既往未接受治疗的晚期卵巢癌中,采用1小时输注递增剂量紫杉醇联合固定剂量顺铂:西班牙卵巢癌研究组的一项II期试验
Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-40-S15-43.
4
Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.异环磷酰胺与长春瑞滨(诺维本)用于晚期非小细胞肺癌的Ⅰ期研究初步报告
Semin Oncol. 1996 Apr;23(2 Suppl 5):11-8.
5
Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.多西他赛(1小时)与卡铂(AUC 7.5)联合用于晚期非小细胞肺癌:福克斯蔡斯癌症中心网络的一项II期研究
Semin Oncol. 1996 Dec;23(6 Suppl 16):35-41.
6
A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.一项关于依达曲沙联合长春碱、阿霉素、顺铂和非格司亭(EVAC/G-CSF)用于晚期恶性肿瘤患者的剂量探索性试验:对非小细胞肺癌具有有前景的抗肿瘤活性。
Cancer J Sci Am. 1997 Sep-Oct;3(5):297-302.
7
Salvage weekly paclitaxel in recurrent ovarian cancer.复发性卵巢癌中每周挽救性使用紫杉醇
Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-62-S15-67.
8
Indicine-N-oxide: a new antitumor agent.印度豆碱 - N - 氧化物:一种新型抗肿瘤药物。
Cancer Treat Rep. 1981 Jan-Feb;65(1-2):53-6.
9
Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: results of a phase I/II trial.在经治实体瘤中采用按计划和剂量强化的紫杉醇进行每周1小时静脉输注:一项I/II期试验的结果
Semin Oncol. 1996 Dec;23(6 Suppl 16):32-4.
10
Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.口服依托泊苷治疗复发性或晚期子宫颈鳞状细胞癌:一项妇科肿瘤学组研究
Gynecol Oncol. 1998 Aug;70(2):263-6. doi: 10.1006/gyno.1998.5097.

引用本文的文献

1
L.: From Farm to a Source of Bioactive Compounds with Therapeutic Activity.L.:从农场到具有治疗活性的生物活性化合物来源。
Evid Based Complement Alternat Med. 2021 Jun 1;2021:9965481. doi: 10.1155/2021/9965481. eCollection 2021.
2
Phytochemica: a platform to explore phytochemicals of medicinal plants.《植物化学》:一个探索药用植物中植物化学物质的平台。
Database (Oxford). 2015 Aug 8;2015. doi: 10.1093/database/bav075. Print 2015.
3
New drug development for pediatric oncology.
Invest New Drugs. 1996;14(1):1-10. doi: 10.1007/BF00173677.
4
Phase I trial of indicine-N-oxide in children with leukemia and solid tumors: a Pediatric Oncology Group study.氧化印度獐牙菜碱在儿童白血病和实体瘤中的I期试验:一项儿科肿瘤学组研究。
Cancer Chemother Pharmacol. 1990;26(5):377-9. doi: 10.1007/BF02897298.